Home>>Signaling Pathways>> Chromatin/Epigenetics>> HIF>>Daprodustat(GSK1278863)

Daprodustat(GSK1278863) (Synonyms: GSK1278863)

Catalog No.GC16647

Daprodustat(GSK1278863) (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.

Products are for research use only. Not for human use. We do not sell to patients.

Daprodustat(GSK1278863) Chemical Structure

Cas No.: 960539-70-2

Size Price Stock Qty
5mg
$69.00
In stock
10mg
$105.00
In stock
50mg
$332.00
In stock
100mg
$516.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Background

Daprodustat (GSK1278863) is a HIF-prolyl hydroxylase inhibitor.

Hypoxia stimulates erythropoietin (EPO) release through accumulation of hypoxia-inducible factor 1α (HIF-1α), resulting in an increase of erythrocyte production by the bone marrow. HIF-prolyl hydroxylase inhibitors have been used to selectively activate the PHD-signaling pathway, leading to the stabilization of HIFα subunits, which can affect the transcription of HIF-responsive genes.

In vitro: In-vitro biotransformation data indicated that GSK1278863 was primarily metabolized by CYP2C8 [1].

In vivo: Currently, there is no animal in vivo data published.

Clinical trial: Previous study found that in both Japanese and Caucasian subjects GSK1278863 showed dose-proportional increases in AUCinf, with a 1.3-1.5-fold higher exposure seen in Japanese relative to Caucasians. Such exposure difference could be mainly explained by the observed differences in body weights. Statistically significant increases in erythropoietin, vascular endothelial growth factor (VEGF) and reticulocyte counts were observed in Japanese subjects as compared to placebo. In Caucasians, erythropoietin and VEGF levels were increased in response to the 100 mg dose. Moreover, drug-related adverse events, sucha as headache and abdominal pain, were reported in three Japanese subjects, whereas, headache was reported in three Caucasians [1]. A 28-day, phase 2A, randomized trial showed that GSK1278863 induced an effective EPO response and stimulated non-EPO mechanisms for erythropoiesis in anemic non-dialysis-dependent and dialysis-dependent patients with CKD [2].

References:
[1] Hara K,Takahashi N,Wakamatsu A,Caltabiano S.  Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects. Drug Metab Pharmacokinet.2015 Dec;30(6):410-8.
[2] Brigandi RA,Johnson B,Oei C,et al.  A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial. Am J Kidney Dis.2016 Jun;67(6):861-71.

Chemical Properties

Cas No. 960539-70-2 SDF
Synonyms GSK1278863
Chemical Name 2-(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carboxamido)acetic acid
Canonical SMILES O=C(O)CNC(C(C(N1C2CCCCC2)=O)C(N(C1=O)C3CCCCC3)=O)=O
Formula C19H27N3O6 M.Wt 393.43
Solubility ≥ 7.86mg/mL in DMSO with gentle warming Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.5417 mL 12.7087 mL 25.4175 mL
5 mM 0.5083 mL 2.5417 mL 5.0835 mL
10 mM 0.2542 mL 1.2709 mL 2.5417 mL
  • Molarity Calculator

  • Dilution Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Reviews

Review for Daprodustat(GSK1278863)

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Daprodustat(GSK1278863)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.